Idexx Laboratories Inc (IDXX) Stock Price, Quote & AI Analysis

Live IDXX stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Idexx Laboratories Inc.

TradeVae provides AI-driven analysis and real-time market intelligence for Idexx Laboratories Inc (IDXX), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.

IDXX
Idexx Laboratories Inc
real-time
$0.00 +0.00 (+0.00%)
Open
565.890000
High
577.490000
Low
555.525000
Volume
631,301
VWAP
-
Market Cap
$44,232,062,907.81
52W Range
$506.91 - $769.98
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Aug 3, 2026 Q2
Before Open
EPS Estimate: $4.0071
Revenue Estimate: $1,222,401,660.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Idexx Laboratories Inc's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Idexx Laboratories Inc Overview

Company information

Company Overview

IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other. The CAG segment provides diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment offers innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water. The LPD segment develops diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food. The Other segment is composed of products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983, and is headquartered in Westbrook, ME.

Company Details
Market Cap
$44.57B
Shares Outstanding
78,883,000
Weighted Shares Outstanding
78,882,997
CEO
Michael Erickson
Address
ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
Employees
11,000
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and indicators

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Idexx Laboratories Inc Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...